In this Section:
Researchers at Austin LifeSciences often run clinical trials that need participants from the local community.
All clinical trials conducted at Austin Health are done so under Australian and International guidelines for medical research under the approval of Austin Health Human Research Ethics Committee (HREC).
If you are an Austin LifeSciences researcher and would like to list a trial here, please email a request with a copy of your HREC-approved advertisement to firstname.lastname@example.org
The Sleep Research Laboratory at University of Melbourne and the Institute for Breathing and Sleep at Austin Health are recruiting obstructive sleep apnoea patients, 30-45 years old, for a study on memory and mood.
Participation involves a 1.5 hour session at the Sleep Laboratory, where you will be asked to complete some questionnaires and memory tasks.
Participants will be reimbursed for their time. University of Melbourne HREC#1239101.
Enquiries: Melinda Jackson 90356129
We are conducting a research study investigating the effect of fatigue on driving performance.
Participation in the study will involve monitoring your driving habits and eye blinks for 7 days. You will be asked to fill out a driving diary and wear special glasses when you drive. The glasses will not affect your ability to drive.
This study may be suitable for you if you:
- Are aged between 21- 80 years
- Are a non-smoker
- Have held a current driver license for at least 3 years
- Have driven an average of 5000km or more per year
To assess your suitability for this study you will be asked questions regarding your personal information (e.g. height and weight), health (e.g. medications) and lifestyle (e.g. driving habits).
This study has been approved by the Austin Health Research Ethics Committee (HREC number: H2011/03994)
For information contact: Sophie Turner on 9496 3517 or e-mail Sophie.Turner@austin.org.au
Do you have type 2 diabetes AND kidney disease caused by your diabetes AND are currently on blood pressure medication?
You may be eligible to participate in a clinical research study of a new drug that is being conducted at Austin Health. The new drug is a tablet taken once a day along with your current medication.
This project has been approved by the Austin Health and St Vincent's Hospital (Melbourne) Human Research Ethics Committee: HREC/15/SVHM/84
If the answer to both questions is Yes, you may be able to take part in a clinical research study.
The CREDENCETM Study is looking at an investigational (study) medication (taken as a daily capsule) that may help protect the kidneys in people with type 2 diabetes.
We are looking for people who:
• Are 30 years of age or older
• Have a diagnosis of type 2 diabetes
• Have kidney problems related to their diabetes
• Are currently taking medicines to control their kidney problems
If you choose to take part in the CREDENCETM Study, you will be looked after by an experienced study team who will carefully monitor your health and support your diabetes management. You will continue to take your current diabetes medications.
For more information please contact: Jodie Prendergast on 9496 4025 or email:mailto:email@example.com
This study has been approved by the Austin Health Human Research Ethics Committee. HREC: 28431754DNE3001
Heart attacks can happen at any time to anyone. It is important to know if you are at risk. There are many factors that increase your chances of having a heart attack including:
• Previous Heart Attack
• Heart Related Disease
• High Cholesterol
• High Blood Pressure
Local physicians are conducting a research study of an investigational medication and its ability to reduce your risk of having a heart attack and other cardiovascular events such as a stroke. If you are currently taking a medication to lower your cholesterol and have one or more of the conditions listed above, you may qualify for participation in this study. All testing, treatment and parking will be provided free of charge. This project has been approved by the Austin Health and St Vincent's Hospital (Melbourne) Human Research Ethics Committee: HREC 12/SVHM/1.
If interested, please contact Tamara Debreceni on 9496 4026 firstname.lastname@example.org
We are testing the effect of an investigational drug on cardiovascular events (heart attack and stroke) in patients with Type 2 Diabetes who may be at risk of these events. If you are male or female aged 50 years or older have Type 2 Diabetes and have never had a heart attack or stroke, you may qualify for a clinical trial. You will be medically supervised. There will be no costs involved. Visits are at the Metabolic Disorders Centre, Austin Health, Heidelberg Repatriation Hospital. This project has been approved by the Austin Health and St Vincent’s Hospital (Melbourne) Human Research Ethics Committee D: HREC D513BC00001.
If interested, please contact Tamara Debreceni on 9496 4026 email@example.com
Researchers are recruiting women aged 18-38 with a BMI>30 who wish to lose weight before planning to become pregnant in the next 6 months. Participants will be placed on a 3 month weight loss plan and will then be observed prior to and during pregnancy. Trial visits are held at the Metabolic Disorders Centre, Austin Health, Heidelberg Repatriation Hospital. All testing, treatment and parking will be provided free of charge. This study has been approved by the Austin Health and Melbourne Health Human Research Ethics Committee: HREC /14/MH/71
To find out more, contact Dr Sarah Price (03) 9496 6221 or firstname.lastname@example.org OR visit our website www.popstudy.com.au
The Department of Endocrinology is recruiting people for a drug trial comparing estradiol skin gel and a placebo skin gel (inactive medication).
Potential participants should be receiving androgen deprivation therapy to treat prostate cancer.
Participants in the study will be asked to attend Austin Health four times over a period of six months.
If you are interested and would like further information, please contact Dr Nick Russell on 03 9496 5000.
This study has been approved by the Austin Health Human Research Ethics Committee Reference Number HREC/16/Austin/98.
If you are about to start gender transition with hormone therapy (or a health volunteer not undergoing transition) you may be eligible to take part in a clinical research study. We are studying the changes that occur with hormone therapy on bone, fat, muscle and cardiovascular risk. The study involves questionnaires, bloods tests, and two scans (DXA/body composition and a bone CT).
We are looking for people:
- Age 18 years or older
- About to start gender transition
- Otherwise fit and healthy
- Not previously on gender affirming hormone therapy
- No previously diagnosed bone disease such as osteoporosis
- Willing to attend 5 visits over 2 years
- We are also looking for healthy volunteers (who are not undergoing gender transition)
If you choose to take part, you will be looked after by an experienced study team who will carefully monitor your health. You will continue to take any current medications.
For more information please contact: Dr Ingrid Bretherton on 9496 2486 or email: email@example.com
This study has been approved by the Austin Health Human Research Ethics Committee: HREC17Austin74
The Austin Liver Transplant Unit is conducting a study looking at an autoimmune liver disease called Primary Biliary Cirrhosis.
We are looking for healthy controls without liver disease to be control subjects for the study. Your participation would involve a one-off interview, which would make a meaningful contribution to PBC research.
This study has been approved by the Austin Health Human Research Ethics Committee; HREC Reference Number H2013/04857.
If you are interested in participating, please contact Dr Janine French (Hepatology Fellow) on 03 9496 5353 or email firstname.lastname@example.org for further information.
The Austin Endocrine Department, in collaboration with the Mercy Hospital for Women, is conducting a study looking at kidney function in pregnancy.
We are looking for women aged less than 40 who are planning pregnancy or under 12 weeks pregnant. Eligible women will have their kidney function measured prior to (if applicable), during and after pregnancy.
This project has been approved by the Austin Health Human Research Ethics Committee.
If you are interested in participating, please contact Dr Jenny Huynh (Endocrine Fellow) on 03 9496 2260 or email@example.com for further information.
A Clinical research study is open to enrollment at Austin Health for patients with inoperable or metastatic melanoma to evaluate a new cancer vaccine in combination with Yervoy®.
In order to participate, you must be:
- Have radiologically measurable disease
- Able to provide a tumour sample to test your suitability to participate
- At least 3 weeks since surgery at enrollment
- Able to meet other health related participation criteria
Patients enrolled on this study may be on the study for up to 12 months. Details of this study can be found at http://clinicaltrials.gov/show/NCT01810016. Please contact you oncologist or the Austin Health Cancer clinical Trials Centre on 03 9496 3088 to see if you may be suitable for this trial.
This study has been approved by the Austin Health Human Research Ethics Committee.
The Parent-Infant Research Institute at Austin Health is conducting a study to evaluate a new internet-based treatment program targeted for women experiencing postnatal depression. If you feel you are struggling to cope or experiencing postnatal depression, this program may be of benefit to you.
Each participant receives a phone assessment with a psychologist to discuss treatment options and to link you in with support services.
Participants will be randomly allocated to receive either the Internet-based treatment (MumMoodBooster) program, or routine primary care.
Participants will be asked to complete questionnaires and phone assessments at three time points over three months.
Each participant will be reimbursed for their time completing the questionnaires and for a telephone assessment interview ($35 in total).
The Internet-based treatment is free of charge.
This study has been approved by the Human Research Ethics Committee of Austin Health. For more information and eligibility criteria, contact the Parent-Infant Research Institute on 9496 4496 or firstname.lastname@example.org.
A collaborative study between Austin Health, Melbourne Health and Victoria University investigating a method of improving walking to reduce tripping in people who have had a stroke is currently seeking participants.
You may be eligible to participate if you:
What will you be asked to do?
If you feel you might be eligible and are interested in participating, please contact Joanne Quek for further information [phone: 9496 2659 or email: email@example.com ]
This study has been approved by the Austin Health Human Research Ethics Committee Reference Number HREC/15/Austin/516.
If yes, we are seeking volunteers with type 2 diabetes who are interested in participating in a placebo-controlled weight loss research study of an investigational medication.
You may qualify for the trial if:
For more information or to see if this trial is suitable for you, please contact Research Coordinator, Austin Health, Nicky 9496 2645 or email: ClinicalTrials-UoMrepat@unimelb.edu.au
This research study has been approved by the Austin Health Human Research Ethics Committee (HREC ZAF-203)
Research into Preventing Diabetes Type 2 using Testosterone & Healthy Lifestyle
Free access to Weight Watchers
The Department of Medicine at Austin Health is recruiting men aged 50-74 years, with a waist circumference of 95cm or greater.
Participants would need to be available every 3 months for injection of testosterone or placebo & blood tests.
For further information or to screen yourself for eligibility go to: www.t4dm.org.au click on Join T4DM & complete questionnaire
or contact Jenny Healy on 03 9496 2282 or email t4dm-Austin@unimelb.edu.au
This trial has been approved by the Austin Health Human Research Ethics Committee